现金流量表(Fortress Biotech Inc Series A Pfd)
2024年中报 | 2024年一季报 | 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
---|---|---|---|---|---|---|---|---|---|---|
起始日期 | 2024-01-01 | 2024-01-01 | 2023-01-01 | 2023-01-01 | 2023-01-01 | 2023-01-01 | 2022-01-01 | 2022-01-01 | 2022-01-01 | 2022-01-01 |
报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
经营活动产生的现金流量: | ||||||||||
净利润(元) | -67,846,000.00 | -39,023,000.00 | -154,154,000.00 | -125,170,000.00 | -114,446,000.00 | -55,145,000.00 | -213,913,000.00 | -156,468,000.00 | -103,408,000.00 | -49,478,000.00 |
折旧及摊销(元) | 3,747,000.00 | 1,800,000.00 | 9,029,000.00 | 7,329,000.00 | 5,481,000.00 | 3,081,000.00 | 11,418,000.00 | 8,261,000.00 | 5,364,000.00 | 2,585,000.00 |
基于股票的补偿费(元) | 9,856,000.00 | 4,857,000.00 | 17,029,000.00 | 13,325,000.00 | 8,948,000.00 | 4,731,000.00 | 22,987,000.00 | 17,481,000.00 | 10,644,000.00 | 5,563,000.00 |
减值及拨备(元) | 2,801,000.00 | 6,000.00 | 3,578,000.00 | 3,635,000.00 | 3,497,000.00 | 126,000.00 | 284,000.00 | 10,000.00 | -45,000.00 | -76,000.00 |
资产处置损益(元) | 29,000.00 | - | -1,466,000.00 | -1,351,000.00 | - | - | 255,000.00 | 255,000.00 | 239,000.00 | - |
投资损益(元) | 114,000.00 | 68,000.00 | 3,062,000.00 | 2,796,000.00 | 2,796,000.00 | - | - | - | - | - |
重估盈余(元) | - | 93,000.00 | -4,424,000.00 | -10,708,000.00 | -6,166,000.00 | -6,678,000.00 | -1,129,000.00 | - | - | - |
经营业务调整其他项目(元) | 1,601,000.00 | 1,147,000.00 | 11,640,000.00 | 11,220,000.00 | 9,482,000.00 | 4,519,000.00 | 1,412,000.00 | 632,000.00 | 383,000.00 | 203,000.00 |
存货的减少(增加)(元) | 519,000.00 | -374,000.00 | 3,953,000.00 | 3,135,000.00 | 1,993,000.00 | 881,000.00 | 1,744,000.00 | 673,000.00 | -150,000.00 | -234,000.00 |
预付款项及其他应收款减少(增加)(元) | 1,837,000.00 | -1,571,000.00 | -848,000.00 | 3,217,000.00 | 2,243,000.00 | 1,199,000.00 | -2,595,000.00 | 1,339,000.00 | - | - |
待摊费用及其他资产(元) | - | - | - | - | - | - | - | - | 1,977,000.00 | 1,468,000.00 |
应收账款及票据减少(增加)(元) | 4,605,000.00 | 5,417,000.00 | 12,551,000.00 | 19,727,000.00 | 10,897,000.00 | 466,000.00 | -5,380,000.00 | -5,431,000.00 | -5,514,000.00 | -7,995,000.00 |
应付账款及票据增加(减少)(元) | -2,837,000.00 | 2,668,000.00 | -24,382,000.00 | -17,018,000.00 | 433,000.00 | 4,774,000.00 | 8,349,000.00 | 4,410,000.00 | 4,197,000.00 | 2,188,000.00 |
应收关联方款项减少(增加)(元) | -57,000.00 | -157,000.00 | -29,000.00 | -27,000.00 | -135,000.00 | -498,000.00 | 540,000.00 | 525,000.00 | 302,000.00 | 47,000.00 |
递延收入(元) | - | - | - | - | -364,000.00 | -181,000.00 | -1,883,000.00 | -1,518,000.00 | -1,154,000.00 | -577,000.00 |
应付税项(元) | -37,000.00 | - | 121,000.00 | 84,000.00 | 1,000.00 | - | 377,000.00 | 13,000.00 | - | 1,000.00 |
应计费用及其他负债(元) | - | - | - | - | - | - | - | - | -93,000.00 | -47,000.00 |
经营业务其他项目(元) | -1,557,000.00 | -318,000.00 | -3,885,000.00 | -3,484,000.00 | -1,171,000.00 | -495,000.00 | -1,867,000.00 | -1,739,000.00 | -1,026,000.00 | -508,000.00 |
经营活动产生的现金流量净额(元) | -47,225,000.00 | -25,387,000.00 | -128,225,000.00 | -93,290,000.00 | -76,511,000.00 | -43,220,000.00 | -179,401,000.00 | -131,557,000.00 | -88,284,000.00 | -46,860,000.00 |
投资活动产生的现金流量: | ||||||||||
购买固定资产支付的现金(元) | - | - | -63,000.00 | -35,000.00 | -34,000.00 | - | -2,715,000.00 | -2,624,000.00 | -1,644,000.00 | -1,337,000.00 |
处置固定资产收到的现金(元) | - | - | 6,000,000.00 | 6,000,000.00 | - | - | - | - | - | - |
购买无形资产及其他资产支付的现金(元) | - | - | -5,000,000.00 | -5,000,000.00 | -5,000,000.00 | - | - | - | - | - |
收购附属公司(元) | - | - | - | - | - | -5,000,000.00 | -20,000,000.00 | -20,000,000.00 | -20,000,000.00 | -20,000,000.00 |
投资业务其他项目(元) | - | - | -3,040,000.00 | -3,005,000.00 | -2,005,000.00 | - | -213,000.00 | 87,000.00 | - | - |
投资活动产生的现金流量净额(元) | - | - | -2,103,000.00 | -2,040,000.00 | -7,039,000.00 | -5,000,000.00 | -22,928,000.00 | -22,537,000.00 | -21,644,000.00 | -21,337,000.00 |
融资活动产生的现金流量: | ||||||||||
发行股份(元) | 40,988,000.00 | 25,283,000.00 | 81,230,000.00 | 50,123,000.00 | 39,725,000.00 | 24,531,000.00 | 42,965,000.00 | 22,042,000.00 | 5,626,000.00 | 4,226,000.00 |
股息支付(元) | -4,368,000.00 | -2,184,000.00 | -8,768,000.00 | -6,580,000.00 | -4,387,000.00 | -2,194,000.00 | -8,780,000.00 | -6,587,000.00 | -4,391,000.00 | -2,195,000.00 |
行使股票期权所得(元) | 371,000.00 | 4,627,000.00 | 503,000.00 | - | - | - | - | - | - | - |
贷款收益(元) | - | - | -39,794,000.00 | -54,414,000.00 | -43,413,000.00 | 52,000.00 | -2,864,000.00 | -3,812,000.00 | 42,112,000.00 | - |
发行费用相关(元) | - | - | -210,000.00 | -210,000.00 | -210,000.00 | -202,000.00 | -597,000.00 | -214,000.00 | -214,000.00 | -214,000.00 |
筹资业务其他项目(元) | 5,133,000.00 | 133,000.00 | -222,000.00 | 202,000.00 | 91,000.00 | - | 44,595,000.00 | 45,272,000.00 | 9,822,000.00 | 48,147,000.00 |
融资活动产生的现金流量净额(元) | 42,124,000.00 | 27,859,000.00 | 32,739,000.00 | -10,879,000.00 | -8,194,000.00 | 22,187,000.00 | 75,319,000.00 | 56,701,000.00 | 52,955,000.00 | 49,964,000.00 |
现金及现金等价物期初余额(元) | 83,365,000.00 | 83,365,000.00 | 180,954,000.00 | 180,954,000.00 | 180,954,000.00 | 180,954,000.00 | 307,964,000.00 | 307,964,000.00 | 307,964,000.00 | 307,964,000.00 |
现金及现金等价物增加(减少)额(元) | -5,101,000.00 | 2,472,000.00 | -97,589,000.00 | -106,209,000.00 | -91,744,000.00 | -26,033,000.00 | -127,010,000.00 | -97,393,000.00 | -56,973,000.00 | -18,233,000.00 |
现金及现金等价物期末余额(元) | 78,264,000.00 | 85,837,000.00 | 83,365,000.00 | 74,745,000.00 | 89,210,000.00 | 154,921,000.00 | 180,954,000.00 | 210,571,000.00 | 250,991,000.00 | 289,731,000.00 |
利息支付(元) | 3,536,000.00 | 1,658,000.00 | 7,945,000.00 | 6,590,000.00 | 5,131,000.00 | 2,885,000.00 | 9,419,000.00 | 6,595,000.00 | 3,987,000.00 | 1,556,000.00 |
所得税支付(元) | 115,000.00 | - | -55,000.00 | -17,000.00 | -52,000.00 | - | 858,000.00 | 1,462,000.00 | 166,000.00 | 107,000.00 |
补充资料其他项目(元) | 3,408,000.00 | 150,000.00 | 1,269,000.00 | 812,000.00 | 4,724,000.00 | 237,000.00 | 10,111,000.00 | 8,374,000.00 | - | - |
非现金活动(元) | - | - | - | - | - | - | - | - | 6,492,000.00 | 6,228,000.00 |
公告日期 | 2024-08-13 | 2024-05-15 | 2024-03-28 | 2023-11-14 | 2023-08-14 | 2023-05-15 | 2023-03-31 | 2022-11-14 | 2022-08-11 | 2022-05-12 |
会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
审计意见 | ||||||||||
核数师 |